Who owns the EVEREST CLINICAL RESEARCH trademark?

The EVEREST CLINICAL RESEARCH trademark is owned by Everest Clinical Research Corporation.

What class is the EVEREST CLINICAL RESEARCH trademark registered in?

The EVEREST CLINICAL RESEARCH trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for EVEREST CLINICAL RESEARCH?

The USPTO serial number for EVEREST CLINICAL RESEARCH is 99119353.

What is the registration number for EVEREST CLINICAL RESEARCH?

EVEREST CLINICAL RESEARCH is registered under USPTO registration number 8267120.

EVE

USPTO Trademark Record

REGISTERED

EVEREST CLINICAL RESEARCH

SN 99119353·Reg 8267120·Filed Apr 03, 2025

Owner Everest Clinical Research Corporation

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

EVEREST CLINICAL RESEARCH (Serial No. 99119353), Registration No. 8267120, is a registered US trademark filed on Apr 03, 2025 by Everest Clinical Research Corporation. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: May 19, 2032

Mark Intelligence

EVEREST CLINICAL RESEARCH (Reg. #8267120) is a registered US trademark that has been protecting its owner, Everest Clinical Research Corporation, since 2025. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 03, 2025

SERIAL

99119353

REG#

8267120

REGISTERED

May 19, 2026

Owner

Applicant

Everest Clinical Research Corporation

Entity

Corporation

Address

East Tower, 4th Floor, 675 Cochrane Drive, Markham, l3r0b8

Country

Attorney

NameCamille M. Miller

Law firm

Camille M. Miller Cozen O'Connor

Docket

ECRS0011US/tbd

Address

1650 Market Street, Suite 2800, Philadelphia, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 03, 2025

Serial Number99119353

Registration No.8267120

Registration DateMay 19, 2026

Status DateMay 19, 2026

Published for OppositionSep 30, 2025

Mark TypeDesign with words

Attorney DocketECRS0011US/tbd

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 07, 2025

First use in commerce: Oct 07, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

REGISTERED-PRINCIPAL REGISTER

May 19, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 19, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 19, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 26, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 26, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 25, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 25, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Dec 01, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 01, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 25, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 30, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 30, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 24, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Sep 02, 2025

ASSIGNED TO EXAMINER

EXAMINERS AMENDMENT -WRITTEN

Sep 02, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Sep 02, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 02, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Sep 02, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 02, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 15, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Apr 03, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Apr 03, 2025

APPLICATION FILING RECEIPT MAILED

EVEREST CLINICAL RESEARCH

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Everest Clinical Research Corporation

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Camille M. Miller

Resources

Company